SPC
GHDX

Sigma Planning Corp’s Genomic Health, Inc. GHDX Stock Holding History

Sigma Planning Corp’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,900
Closed -$251K – 1000
2018
Q4 		$251K Hold
3,900
– – 0.02% 674
2018
Q3 		$274K Buy
+3,900
New +$228K 0.02% 736

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sigma Planning Corp's GHDX Position: Q1 2019 in Review

Sigma Planning Corp sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 3,900 shares — an estimated $251K sold.

Sigma Planning Corp first reported a position in GHDX in Q3 2018 and held it in 2 quarters. The position peaked at $274K in Q3 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • Sigma Planning Corp reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • Sigma Planning Corp sold 3,900 Genomic Health, Inc. shares in Q1 2019, an estimated $251K.
  • Sigma Planning Corp first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 2 quarters.
  • Sigma Planning Corp's Genomic Health, Inc. position peaked at $274K in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on Sigma Planning Corp's 13F filing for Q1 2019, filed 1 May 2019.